- Home
- TNXP vs GIGM Comparison
TNXP vs GIGM Comparison
Compare TNXP & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- GIGM
- Stock Information
- Founded
- TNXP 2007
- GIGM 1998
- Country
- TNXP United States
- GIGM Taiwan
- Employees
- TNXP N/A
- GIGM N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- GIGM Computer Software: Programming Data Processing
- Sector
- TNXP Health Care
- GIGM Technology
- Exchange
- TNXP Nasdaq
- GIGM Nasdaq
- Market Cap
- TNXP 15.1M
- GIGM 14.5M
- IPO Year
- TNXP N/A
- GIGM 2000
- Fundamental
- Price
- TNXP $0.13
- GIGM $1.40
- Analyst Decision
- TNXP Strong Buy
- GIGM
- Analyst Count
- TNXP 2
- GIGM 0
- Target Price
- TNXP $53.50
- GIGM N/A
- AVG Volume (30 Days)
- TNXP 35.6M
- GIGM 12.4K
- Earning Date
- TNXP 11-07-2024
- GIGM 10-29-2024
- Dividend Yield
- TNXP N/A
- GIGM N/A
- EPS Growth
- TNXP N/A
- GIGM N/A
- EPS
- TNXP N/A
- GIGM N/A
- Revenue
- TNXP $12,458,000.00
- GIGM $3,387,000.00
- Revenue This Year
- TNXP $62.53
- GIGM N/A
- Revenue Next Year
- TNXP $26.17
- GIGM N/A
- P/E Ratio
- TNXP N/A
- GIGM N/A
- Revenue Growth
- TNXP N/A
- GIGM N/A
- 52 Week Low
- TNXP $0.12
- GIGM $1.23
- 52 Week High
- TNXP $22.08
- GIGM $1.50
- Technical
- Relative Strength Index (RSI)
- TNXP 24.79
- GIGM 56.54
- Support Level
- TNXP $0.14
- GIGM $1.34
- Resistance Level
- TNXP $0.21
- GIGM $1.45
- Average True Range (ATR)
- TNXP 0.01
- GIGM 0.05
- MACD
- TNXP 0.02
- GIGM 0.00
- Stochastic Oscillator
- TNXP 8.70
- GIGM 58.82
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.